NCT02991027撤回不适用
OCT Image Quality Performance Evaluation
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- OCT image quality
研究概览
简要总结
To evaluate the image qualities and segmentation performance of Topcon's DRI OCT Triton devices using two light sources.
详细描述
To evaluate the image qualities and segmentation performance of Topcon's DRI OCT Triton devices using two light sources with equivalent specifications: the micro-electro-mechanical short cavity tunable laser and the micro-electro-mechanical tunable vertical cavity surface emitting laser.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participants must be at least 18 years of age
- •They must be able to complete all testing (all OCT scans)
- •They must volunteer to be in the study and sign the consent form
排除标准
- •Subject with history of ocular disease or ocular pathology
- •Subjects unable to complete all OCT imaging modes
研究组 & 干预措施
Subjects Presenting With Normal Eyes
Experimental
Subjects with no known ocular diseases will be imaged using 2 different light sources using the DRI Triton
干预措施: DRI OCT Triton (Device)
结局指标
主要结局
OCT image quality
时间窗: 5 minutes
OCT angiography image quality
时间窗: 5 minutes
次要结局
- Full Retinal Thickness(5 minutes)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - CorneaCorneal TransplantationNCT05210478Vanderbilt University Medical Center24
Enrolling By Invitation
不适用
Intraoperative Optical Coherence Tomography - NormalsHealthy VolunteersNCT04790890Vanderbilt University Medical Center20
已完成
不适用
Study Comparing the P200TE and the P200TxE in Glaucoma PatientsGlaucomaNCT03912584Optos, PLC10
已完成
不适用
Triton Agreement and Precision StudyHealthy EyesEye DiseasesNCT03080714Topcon Medical Systems, Inc.88
已完成
不适用
Clinical Validation of New OCT SystemSubjects Presenting With Normal or With Ocular PathologyNCT01809704Topcon Medical Systems, Inc.87